VA Tech Wabag Share Price Gains After Securing Large Order from Nepal Government for Water Treatment Plant

On November 20, 2025, VA Tech Wabag announced receiving an ADB funded Large Design Build Operate order from the Melamchi Water Supply Development Board in Nepal for a major water treatment project.
VA Tech Wabag Bags Large ADB Funded DBO Project in Nepal
VA Tech WABAG secured a repeat large order from the Melamchi Water Supply Development Board for designing, building, and operating a 255 MLD Sundarijal Water Treatment Plant in Kathmandu Valley. The project is funded by the Asian Development Bank and involves advanced treatment systems aimed at meeting Nepal’s National Drinking Water Quality Standards.
The new facility will be located next to the existing Melamchi plant built by WABAG in 2017 and will process water from the Melamchi, Yangri, and Larke rivers to enhance water availability for Kathmandu’s rising population.
Project Scope and Execution Timeline
The Engineering Procurement and Construction work will be carried out in over 36 months. After completion, WABAG will operate and maintain the plant for 5 years, highlighting its long-term lifecycle service approach.
The order falls under the large category, defined as a value between $30 million and $75 million. The contract includes design, engineering, supply, construction, installation, commissioning, and later operation and maintenance, ensuring end-to-end delivery.
Read More: Groww Shares Jump 7% on November 18, Taking Gains to Nearly 90% Since Listing!
VA Tech Wabag Share Price Performance
As of November 20, 2025, at 9:41 AM, VA Tech Wabag share price was trading at ₹1,423.00 up by 1.38% from the previous closing price.
Conclusion
The ADB funded project highlights WABAG’s ongoing role in Nepal’s water infrastructure development. With a significant capacity of 255 MLD and a multi-year execution plan, the project strengthens the company’s regional portfolio while supporting long-term water management goals.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Nov 20, 2025, 12:47 PM IST

Team Angel One
- Adani Defence Signs Five-Year Ammunition Supply Agreement for AK-203 Programme
- AstraZeneca Gains FDA Approval for Camizestrant Combo in ESR1-Mutated Advanced Breast Cancer
- CBI Files FIR Against Subhash Chandra Over LIC Housing Finance Loan Fraud Allegations
- Top Gainers and Losers on September 3, 2026: Adani Ports, Axis Bank and HDFC Bank Rise Up to 2%
- Hilton Expands India Presence With 60 Hotels Under Construction, Plans 400 More Properties


